Despite advances in the management of and changes in clinical practice, little is known about the epidemiology, patterns of care and outcomes of rare peritoneal surface malignancies patients in France.
In order to better understand the characteristics of rare peritoneal surface malignancies and to evaluate treatment strategies, the RENAPE registry aims at the collection of data from patients presenting with a rare peritoneal surface malignancy in France. Data will be entered prospectively in a specifically designed and secured web database.
All RENAPE's centres and physicians are invited to register patients with a rare peritoneal surface malignancy diagnosis and to participate to the registry. Data will be evaluated within regular time frames, focusing on types of rare peritoneal surface malignancies, treatment modalities and patient outcomes (e.g. survival, recurrence), thereby contributing to the better understanding of these rare cancers.
|First Received Date||June 30, 2016|
|Last Changed Date||August 18, 2017|
|Start Date||October 2010|
|Anticipated Primary Completion Date||December 2018|
|Primary Outcome Measures||
Incidence of rare peritoneal surface malignancies [Time Frame: year 5]
|Secondary Outcome Measures||
Impact of specific treatment strategies [Time Frame: year 5]
|Study Type||Observational [Patient Registry]|
|Study Arms / Comparison Groups||0 / 7|
|Recruitment Status||Active, not recruiting|
|Ages||N/A - N/A|
|Accepts Healthy Volunteers||No|
- Patients are eligible if they have a histologically proven rare peritoneal surface malignancy.
- Histological diagnostic of peritoneal surface malignancy not confirmed
- Expected clinical follow up data not available
|Sponsor||Hospices Civils de Lyon|
|Verification Date||August 2017|